上海华源制药股份有限公司2007年年度报告(节录)
2008-05-22
21:02:05 来源:上海证券交易所 阅读:
次
-
一、会计数据和业务数据1.主要会计数据单位:(人民币)元主要会计数据2007 年2006 年本年比上年增减(%)调整后调整前调整后营业收入204,102,405.61515,270,593.86506,128,628.98-60.39利润总额161,477,599.09-88,711,483.57-85,875,701.53----归属于上市公司股东的净利润131,448,949.76-78,082,776.57-75,246,994.53----归属于上市公司股东的扣除非经常性损益的净利润-109,464,459.45-81,666,005.70-78,830,223.66----基本每股收益0.88-0.52-0.50----稀释每股收益0.88-0.52-0.50----扣除非经常性损益后的基本每股收益-0.73-0.54-0.83----全面摊薄净资产收益率(%)1,785. 58------------扣除非经常性损益后全面摊薄净资产收益率(%)-1,486.95------------经营活动产生的现金流量净额12,099,853.22-4,808,397.47-4,808,397.47----每股经营活动产生的现金流量净额0.08-0.03-0.03----总资产989,770,723.18523,384,529.60521,024,031.9189.11所有者权益(或股东权益)7,361,679.62-123,587,270.14-107,459,167.83------归属于上市公司股东的每股净资产0.05-0.82-0.72------2.非经常性损益项目单位:(人民币)元(一)非流动资产处置损益822,557.64(二)计入当期损益的政府补助467,202.00(三)除上述各项之外的其他营业外收支净额-3,423,610.14(四)中国证监会认定的其他非经常性损益项目273,734,294.82(五)非经常性损益的所得税影响数-30,693,798.49(六)少数股东损益影响数6,763.38合计240,913,409.21
二、利润及利润分配表
单位:(人民币)元项目合并数母公司数本期数上年同期数本期数上年同期数一、营业收入204,102,405.61515,270,593.86142,738,419.56159,982,281.12减:营业成本187,405,901.68459,735,902.65135,484,583.63150,291,457.63营业税金及附加824,844.691,218,111.02543,804.90848,899.83销售费用10,281,244.6427,521,334.636,464,117.577,146,773.17管理费用51,958,996.4856,189,164.4220,308,783.675,139,733.11财务费用22,228,038.9737,458,997.7521,182,655.7429,324,275.79资产减值损失51,140,177.7412,188,750.3245,113,363.2410,810,811.51加: 公允价值变动收益(损失以"-"填列)投资收益(损失以"-"填列)9,613,953.36-7,473,888.187,180,840.808,185,231.55其中:对联营企业和合营企业的投资收益-1,647,621.85-7,473,888.18-4,156,436.06-6,064,768.45二、营业利润-110,122,845.23-86,515,555.11-79,178,048.39-35,394,438.37加: 营业外收入275,147,924.671,553,256.12275,111,484.01886,957.32减: 营业外支出3,547,480.353,749,184.5862,260.042,231,907.12其中:非流动资产处置损失三、利润总额(亏损总额以"-"填列)161,477,599.09-88,711,483.57195,871,175.58-36,739,388.17减:所得税费用30,693,798.49142,660.4630,693,798.49-696,239.65四、净利润(净亏损以“-”填列)130,783,800.60-88,854,144.03165,177,377.09-36,043,148.52归属于母公司所有者的净利润131,448,949.76-78,082,776.57165,177,377.09-36,043,148.52少数股东损益-665,149.16-10,771,367.46五、每股收益(一)基本每股收益0.88-0.521.10-0.24(二)稀释每股收益0.88-0.521.10-0.24
相关新闻
医药热点